The serum concentration of Prednisone can be increased when it is combined with Voriconazole. The therapeutic efficacy of Metformin can be decreased when used in combination with Prednisone. The risk or severity of adverse effects can be increased when Celecoxib is combined with Prednisone. The metabolism of Prednisone can be decreased when combined with Delavirdine. The serum concentration of Prednisone can be increased when it is combined with Promestriene. The therapeutic efficacy of Prednisone can be decreased when used in combination with Sarilumab. The serum concentration of Prednisone can be increased when it is combined with Luliconazole. Prednisone may increase the fluid retaining activities of Mesterolone. The serum concentration of Saxagliptin can be decreased when it is combined with Prednisone. The bioavailability of Prednisone can be decreased when combined with Bismuth Subcitrate. The risk or severity of adverse effects can be increased when Antipyrine is combined with Prednisone. The metabolism of Prednisone can be decreased when combined with Imatinib. Prednisone may increase the hypokalemic activities of Chlorothiazide. The serum concentration of the active metabolites of Prednisone can be reduced when Prednisone is used in combination with Tesamorelin resulting in a loss in efficacy. The risk or severity of adverse effects can be increased when Nepafenac is combined with Prednisone. The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Prednisone. The serum concentration of Prednisone can be decreased when it is combined with Tocilizumab. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Prednisone. The risk or severity of adverse effects can be increased when Prednisone is combined with Rindopepimut. The risk or severity of adverse effects can be increased when Nicergoline is combined with Prednisone. Deslanoside may decrease the cardiotoxic activities of Prednisone. The therapeutic efficacy of Tolazamide can be decreased when used in combination with Prednisone. The risk or severity of adverse effects can be increased when Prednisone is combined with Enoxacin. The risk or severity of adverse effects can be increased when Olopatadine is combined with Prednisone. The risk or severity of adverse effects can be increased when Cabergoline is combined with Prednisone. The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Prednisone. The risk or severity of adverse effects can be increased when Parecoxib is combined with Prednisone. The risk or severity of adverse effects can be increased when Aloxiprin is combined with Prednisone. The serum concentration of Prednisone can be decreased when it is combined with Siltuximab. The therapeutic efficacy of Troglitazone can be decreased when used in combination with Prednisone. The serum concentration of Prednisone can be decreased when it is combined with Mitotane. The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Prednisone. The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Prednisone. The metabolism of Prednisone can be decreased when combined with Olaparib. The risk or severity of adverse effects can be increased when Epirizole is combined with Prednisone. Acetyldigitoxin may decrease the cardiotoxic activities of Prednisone. The risk or severity of adverse effects can be increased when Ergotamine is combined with Prednisone. Proscillaridin may decrease the cardiotoxic activities of Prednisone. The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Prednisone. The risk or severity of adverse effects can be increased when E-6201 is combined with Prednisone. The serum concentration of Rosuvastatin can be increased when it is combined with Prednisone. The risk or severity of adverse effects can be increased when Prednisone is combined with Malathion. The risk or severity of adverse effects can be increased when Prednisone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Droxicam is combined with Prednisone. The risk or severity of adverse effects can be increased when Suprofen is combined with Prednisone. Prednisone may increase the hypokalemic activities of Polythiazide. The bioavailability of Prednisone can be decreased when combined with Aluminum hydroxide. The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Prednisone. The therapeutic efficacy of Gusperimus can be decreased when used in combination with Prednisone. The serum concentration of Tolvaptan can be increased when it is combined with Prednisone. The metabolism of Prednisone can be decreased when combined with Bortezomib. The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Prednisone. Prednisone may decrease the antineoplastic activities of Aldesleukin. The serum concentration of Ibrutinib can be increased when it is combined with Prednisone. The risk or severity of adverse effects can be increased when Prednisone is combined with Galantamine. The therapeutic efficacy of Pramlintide can be decreased when used in combination with Prednisone. The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Prednisone. The risk or severity of adverse effects can be increased when Nimesulide is combined with Prednisone. The serum concentration of Prednisone can be increased when it is combined with Ceritinib. The risk or severity of adverse effects can be increased when Prednisone is combined with Gallamine Triethiodide. The risk or severity of adverse effects can be increased when Parthenolide is combined with Prednisone. The risk or severity of adverse effects can be increased when Prednisone is combined with Memantine. The risk or severity of adverse effects can be increased when Prednisone is combined with Neostigmine. The bioavailability of Prednisone can be decreased when combined with Aluminium. The risk or severity of adverse effects can be increased when Nafamostat is combined with Prednisone. The serum concentration of Prednisone can be increased when it is combined with Stiripentol. The serum concentration of Prednisone can be increased when it is combined with Atazanavir. The risk or severity of adverse effects can be increased when Mizoribine is combined with Prednisone. The risk or severity of adverse effects can be increased when Aceclofenac is combined with Prednisone. The serum concentration of Prednisone can be increased when it is combined with Ritonavir. The serum concentration of Prednisone can be increased when it is combined with Posaconazole. Digitoxin may decrease the cardiotoxic activities of Prednisone. Prednisone may increase the fluid retaining activities of Dihydrotestosterone. The therapeutic efficacy of Buformin can be decreased when used in combination with Prednisone. The risk or severity of adverse effects can be increased when Fenoprofen is combined with Prednisone. The risk or severity of adverse effects can be increased when Loxoprofen is combined with Prednisone. The risk or severity of adverse effects can be increased when Ibuproxam is combined with Prednisone. The therapeutic efficacy of 2,4-thiazolidinedione can be decreased when used in combination with Prednisone. The risk or severity of adverse effects can be increased when Tarenflurbil is combined with Prednisone. The serum concentration of Prednisone can be decreased when it is combined with Lumacaftor. The risk or severity of adverse effects can be increased when Methysergide is combined with Prednisone. Prednisone may increase the fluid retaining activities of Nandrolone. The serum concentration of Prednisone can be increased when it is combined with Hexestrol. The risk or severity of adverse effects can be increased when Zileuton is combined with Prednisone. The risk or severity of adverse effects can be increased when Sulindac is combined with Prednisone. The metabolism of Prednisone can be decreased when combined with Fosamprenavir. Prednisone may increase the hypokalemic activities of Etacrynic acid. The serum concentration of Prednisone can be decreased when it is combined with Rifampicin. The risk or severity of adverse effects can be increased when Metamizole is combined with Prednisone. The risk or severity of adverse effects can be increased when Prednisone is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated). The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Prednisone. The therapeutic efficacy of Glipizide can be decreased when used in combination with Prednisone. The risk or severity of adverse effects can be increased when Prednisone is combined with INGN 225. The serum concentration of Prednisone can be decreased when it is combined with Dabrafenib. The risk or severity of adverse effects can be increased when Paclitaxel is combined with Prednisone. The therapeutic efficacy of Miglustat can be decreased when used in combination with Prednisone. The serum concentration of Isoniazid can be decreased when it is combined with Prednisone. The therapeutic efficacy of Insulin Glargine can be decreased when used in combination with Prednisone. The risk or severity of adverse effects can be increased when Kebuzone is combined with Prednisone. The serum concentration of Prednisone can be increased when it is combined with Simeprevir. The risk or severity of adverse effects can be increased when Salsalate is combined with Prednisone. The risk or severity of adverse effects can be increased when Adapalene is combined with Prednisone. The metabolism of Prednisone can be decreased when combined with Fluvoxamine. The risk or severity of adverse effects can be increased when Tranilast is combined with Prednisone. The risk or severity of adverse effects can be increased when Prednisone is combined with Hepatitis A Vaccine. Prednisone may increase the fluid retaining activities of Stanozolol. The serum concentration of Prednisone can be decreased when it is combined with Primidone. The therapeutic efficacy of Phenformin can be decreased when used in combination with Prednisone. The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Prednisone. The serum concentration of Prednisone can be increased when it is combined with Palbociclib. The serum concentration of Prednisone can be decreased when it is combined with Nevirapine. The serum concentration of Everolimus can be increased when it is combined with Prednisone. Prednisone may increase the hypokalemic activities of Trichlormethiazide. The metabolism of Prednisone can be decreased when combined with Clotrimazole. The risk or severity of adverse effects can be increased when Prednisone is combined with Ginkgo biloba. The risk or severity of adverse effects can be increased when Prednisone is combined with Rosoxacin. The risk or severity of adverse effects can be increased when Prednisone is combined with Metoclopramide. The risk or severity of adverse effects can be increased when Prednisone is combined with Cinoxacin. The serum concentration of Prednisone can be increased when it is combined with Estriol. The serum concentration of Naloxegol can be increased when it is combined with Prednisone. The risk or severity of adverse effects can be increased when Alclofenac is combined with Prednisone. The risk or severity of adverse effects can be increased when Prednisone is combined with Salmonella typhi ty21a live antigen. The metabolism of Prednisone can be decreased when combined with Ziprasidone. The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Prednisone. The risk or severity of adverse effects can be increased when Apocynin is combined with Prednisone. The serum concentration of Prednisone can be increased when it is combined with Indinavir. The risk or severity of adverse effects can be increased when Prednisone is combined with Norfloxacin. Atracurium besylate may increase the adverse neuromuscular activities of Prednisone. The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Prednisone. Prednisone may increase the hypokalemic activities of Hydroflumethiazide.